Ex Parte Reuter et al

8 Cited authorities

  1. Abbvie Inc. v. Mathilda & Terence Kennedy Inst. of Rheumatology Trust

    764 F.3d 1366 (Fed. Cir. 2014)   Cited 45 times   23 Legal Analyses
    Affirming a claim construction that was supported by the intrinsic evidence and the inventor's testimony
  2. Application of Best

    562 F.2d 1252 (C.C.P.A. 1977)   Cited 18 times   4 Legal Analyses

    Patent Appeal No. 77-509. October 13, 1977. Richard G. Miller, New York City, attorney of record, for appellants, James C. Arvantes, Arlington, Va., of counsel. Joseph F. Nakamura, Washington, D.C., for the Commissioner of Patents, Gerald H. Bjorge, Washington, D.C., of counsel. Appeal from the Patent and Trademark Office Board of Appeals. Before MARKEY, C.J., RICH, BALDWIN and LANE, JJ., and FORD, J., United States Customs Court. MARKEY, Chief Judge. Appeal from the decision of the Patent and Trademark

  3. In re Pleuddemann

    910 F.2d 823 (Fed. Cir. 1990)   Cited 2 times   1 Legal Analyses

    No. 89-1510. August 3, 1990. Timothy W. Hagan (argued), Killworth, Gottman, Hagan Schaeff, Dayton, Ohio, for appellant. With him on the brief, was Richard A. Killworth. Also on the brief, were Alexander Weitz and Robert L. McKellar, Dow Corning Corp., Midland, Mich., of counsel. Richard E. Schafer (argued), Associate Sol., Office of Sol., Arlington, Va., for appellee. With him on the brief, was Fred E. McKelvey, Sol. Appeal from the United States Patent and Trademark Office Board of Patent Appeals

  4. Application of Kaufmann

    451 F.2d 1096 (C.C.P.A. 1971)

    Patent Appeal No. 8569. December 16, 1971. Donal E. McCarthy of McCarthy, Depaoli O'Brien, Washington, D.C., atty. of record, for appellants. S. Wm. Cochran, Washington, D.C., for the Commissioner of Patents. R. E. Martin, Washington, D.C., of counsel. Appeal from the Board of Appeals of the United States Patent Office. Before WORLEY, Chief Judge, and RICH, ALMOND, BALDWIN and LANE, Judges. ALMOND, Judge. This is an appeal from the decision of the Patent Office Board of Appeals affirming the rejection

  5. Section 103 - Conditions for patentability; non-obvious subject matter

    35 U.S.C. § 103   Cited 6,129 times   479 Legal Analyses
    Holding the party seeking invalidity must prove "the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains."
  6. Section 6 - Patent Trial and Appeal Board

    35 U.S.C. § 6   Cited 186 times   63 Legal Analyses
    Giving the Director authority to designate "at least 3 members of the Patent Trial and Appeal Board" to review "[e]ach appeal, derivation proceeding, post-grant review, and inter partes review"
  7. Section 134 - Appeal to the Patent Trial and Appeal Board

    35 U.S.C. § 134   Cited 98 times   30 Legal Analyses

    (a) PATENT APPLICANT.-An applicant for a patent, any of whose claims has been twice rejected, may appeal from the decision of the primary examiner to the Patent Trial and Appeal Board, having once paid the fee for such appeal. (b) PATENT OWNER.-A patent owner in a reexamination may appeal from the final rejection of any claim by the primary examiner to the Patent Trial and Appeal Board, having once paid the fee for such appeal. 35 U.S.C. § 134 July 19, 1952, ch. 950, 66 Stat. 801; Pub. L. 98-622

  8. Section 1.136 - Extensions of time

    37 C.F.R. § 1.136   Cited 17 times   30 Legal Analyses

    (a) (1) If an applicant is required to reply within a nonstatutory or shortened statutory time period, applicant may extend the time period for reply up to the earlier of the expiration of any maximum period set by statute or five months after the time period set for reply, if a petition for an extension of time and the fee set in § 1.17(a) are filed, unless: (i) Applicant is notified otherwise in an Office action; (ii) The reply is a reply brief submitted pursuant to § 41.41 of this title; (iii)